Aurinia Pharmaceuticals Inc. AUPH 深 滬
等待開盤 11-12 09:30:00 美东时间
15.895
-0.405
-2.48%
華盛通- 最 高16.36
- 今 開16.28
- 成交量 19.11万股
- 最 低 15.8664
- 昨 收 16.30
- 總市值 212.99万
- 52周最高 19.25
- 市盈率 靜 7.68
- 換手率 0.14%
- 52周最低 13.52
- 委 比 -49.25%
- 總股本 0.00亿
- 歷史最高 33.972
- 量 比 0.52
- 振 幅 3.03%
- 歷史最低 1.41
- 每 手 1
- 風險率 0.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aurinia Pharmaceuticals Inc收涨0.97%，成交额1128.56万美元
11月10日，Aurinia Pharmaceuticals Inc（AUPH）收涨0.97%，报16.62美元，成交额1128.56万美元，市值22.27亿美...
11-10 06:24
美股大行评级 | 潜在涨幅2250.23%！艾伯维获大摩等多家大行上调目标价，最高340美元
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从50美元升至51美元；HC Wainwright & Co.：上调伊诺维奥制药评级至"买入"，目标价5美元
11-03 18:20
Aurinia Pharmaceuticals Inc收跌3.06%，成交额2609.13万美元
11月3日，Aurinia Pharmaceuticals Inc（AUPH）收跌3.06%，报16.14美元，成交额2609.13万美元，市值21.47亿美元...
11-03 06:24
Why Is Teva Stock Trading Lower on Monday?
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), will discontinue its Phase 2 TOPAS-MSA study evaluating emrusolmin in adult patients with multiple system atrophy. Interim Futility Analysis Signals Low Efficacy Probability The company decided on a recommenda...
11-02 23:01
RBC Capital Maintains Sector Perform on Aurinia Pharmaceuticals, Raises Price Target to $18
RBC Capital analyst Douglas Miehm maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Sector Perform and raises the price target from $16 to $18.
11-02 22:43
Aurinia Pharmaceuticals Raises FY2026 Sales Guidance from $315.000M-$325.000M to $325.000M-$330.000M vs $330.261M Est
Aurinia Pharmaceuticals (NASDAQ:AUPH) raises FY2026 sales outlook from $315.000 million-$325.000 million to $325.000 million-$330.000 million vs $330.261 million estimate.
10-30 20:20
Aurinia Pharmaceuticals Q3 EPS $0.23 Beats $0.22 Estimate, Sales $83.699M Beat $83.691M Estimate
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.22 by 4.55 percent. This is unchanged from the same period last year. The company reported quarterly sales of $83.699 million which beat the analyst consensus estimate...
10-30 20:06
Aurinia Pharmaceuticals Inc收涨1.07%，成交额1351.55万美元
10月27日，Aurinia Pharmaceuticals Inc（AUPH）收涨1.07%，报17.04美元，成交额1351.55万美元，市值22.67亿美...
10-27 05:24
Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer
Adial Pharmaceuticals announced that Celia Economides, its current Executive Vice President of Finance, is expected to be appointed Chief Financial Officer, succeeding Vinay Shah. Economides brings over two decades of experience in biotech finance, having raised over $1 billion in financings. She will lead the Company’s finance organization as it transitions to Azora Therapeutics and advances AT177 toward the clinic. Adial plans to change its nam...
10-26 12:00
美股大行评级 | 潜在涨幅227.21%！Jones Trading上调Rapport Therapeutics(RAPP)目标价至82美元，维持"买入"评级
今日重点评级关注：Jones Trading：维持Rapport Therapeutics"买入"评级，目标价从50美元升至82美元；摩根大通：维持SpaceX"超配"评级，目标价从240美元升至500美元
10-22 11:59
